Describe attributions for risk, sources of risk education, and timing of risk education among male survivors' who perceive themselves to be at high risk for male health problems. Identify differences in attributions, education, and timing among survivors who correctly versus incorrectly classify their risk status based on medical treatment history.
Hypothesis-Male survivors of childhood cancers who correctly classify their risk status (Group 1: At-Risk & Aware) will report more sources of education and multiple discussions of risk over time as compared to survivors who incorrectly identify themselves as high risk (Group 2: Low risk & Unaware).
Exploratory Aim: PERCEIVED MALE HEALTH RISK & CURRENT SEXUAL FUNCTIONING
To explore potential differences in male survivors' self-reported current sexual functioning based on perceived risk-gonadotoxic history group classification. Hypothesis-Male survivors of childhood cancers who perceive themselves to be at high risk for infertility, low testosterone levels, and sexual dysfunction (Group 1: At-Risk & Aware and Group 2: Low risk & Unaware) will report more problems with sexual functioning as compared to survivors who do not perceive themselves to be at risk for male health problems ( F1a "Slightly more"/ "Much more" & No history of gonadotoxic treatment history  Group 3 At-Risk & Unaware:
F1a "Much less"/ "Slightly less"/ "About the same" & History of Alkylating Agents / Cranial radiation > 40 Gy / Testicular radiation / Total Body Irradiation / Orchiectomy  Group 4 Low risk & Aware:
F1a "Much less"/ "Slightly less"/ "About the -2007) , and health status variables (MHQ, see above) are associated with the likelihood that a survivor is aware of his true risk exposure status. Modeling of the awareness outcome will be conducted separately for subjects who were and who were not exposed to gonadotoxic therapies, since the factors that are associated with awareness of high risk may be different than the factors that are associated with awareness of low risk. Univariable modeling will be performed first and any variables that show a univariable association with the awareness outcome at the p<0.10 level will be assessed further in multivariable modeling. Statistical analysis-Descriptive statistics of subject characteristics and outcome variables will be summarized using standard measures for the entire sample and each of the four groups outlined previously. Descriptive statistics for the quality of life outcome variables will be summarized using standard measures for the entire sample and broken out by perceived risk level for each of the three male health problems. Regression modeling will be conducted to evaluate differences in the SF-12 measures of general health, physical functioning, physical and emotional role functioning, mental health, vitality, and social functioning between subjects who perceive themselves to be "more at-risk" vs "same or less at-risk" for male health problems compared to their peers. The influence of demographic variables (e.g. age at MHQ, marital status) on the outcomes will also be assessed and, where appropriate, adjustment for demographic factors will be included in the models.
Aim 3: PERCEIVED MALE HEALTH RISK, ATTRIBUTIONS, & EDUCATION INFORMATION  Population:
o Male survivors responding to MHQ without history of secondary malignancy AND o Responded to MHQ with ANY the following:
 Risk for infertility (F1a) = "Slightly more", "Much more" AND/OR  Risk low testosterone levels (F1b) = "Slightly more", "Much more" AND/OR  Risk sexual dysfunction (F1c) = "Slightly more", "Much more" Statistical analysis-For each of the three identified male health problems (infertility-F1a, low testosterone levels-F1b, and sexual dysfunction-F1c), all participants reporting "slightly more" or "much more" risk will be classified into two groups, based on the accuracy of their perceptions as compared with medical record review of gonadotoxic therapy history (Group 1 or Group 2, as in Aim 1).
Percentages of participants indicating each attribution option (F2a/F2b/F2c), source of information (F3a/F3b/F3c), and time point of risk discussion (F4a/F4b/F4c) will be calculated. The total number of sources of information endorsed will be summed for each male health problem (F3a/F3b/F3c), and ttests will be conducted to determine if survivors who correctly classify their risk accessed more sources of information than survivors whose perception of high risk was inaccurate based on gonadotoxic treatment history. Similarly, the total number of discussions across medical care endorsed will be summed for each male health problem (F4a/F4b/F4c), and t-tests will be conducted to determine if survivors who correctly classify their risk participated in discussion of risk more frequently during their medical care than survivors whose perception of high risk was inaccurate based on gonadotoxic treatment history. Chi square analyses will be conducted to determine if survivors who correctly classify their risk were more likely to participate in recent survivor care (B6-2007) or discussion of sexual health risk during survivor care (from F4a/F4b/F4c) than survivors whose perception of high risk was inaccurate based on gonadotoxic treatment history. 
 Erectile difficulty (G12a > "seldom-less than 25% of the time" AND/OR G12c > "seldom-less than 25% of the time")  Lack of sexual interest or desire (G12b > "seldom-less than 25% of the time")  Anxiety about sexual performance (G12e > "seldom-less than 25% of the time")  Inability to achieve orgasm (G12f > "seldom-less than 25% of the time") Statistical analysis-For each of the three identified male health problems (infertility-F1a, low testosterone levels-F1b, and sexual dysfunction-F1c), participants will be classified into the same four groups as in Aim 1, based on the accuracy of their perceptions as compared with medical record review of gonadotoxic therapy history. Descriptive statistics for each of the sexual function measures will be summarized overall and for each of the four groups. Regression modeling will be conducted to evaluate differences in sexual function measures across the four distinct risk exposure  risk perception groups. The influence of demographic variables (e.g. age at MHQ, marital status) on the outcomes will also be assessed and, where appropriate, adjustment for demographic factors will be included in the models. For the measures that are defined as binary outcomes (erectile difficulty, lack of sexual interest or desire, anxiety about sexual performance and inability to achieve orgasm) a logistic form for the regression model will be used. Table 1 . Infertility Classification Gonadotoxic therapy Self-reported Perceived Risk for Infertility as compared to peers "More" perceived risk:
TABLES

Aims 1, 2, 3 & Exploratory: Male Survivor Perception Classification System
Infertility-F1a "Slightly more/Much more" "Same or less" perceived risk:
Infertility-F1a "Same/Slightly less/Much less"
History of gonadotoxic therapy
Alkylating Agents Cranial radiation > 40 Gy Testicular radiation Total Body Irradiation Orchiectomy 
"Same or less" perceived risk:
Low Testosterone-F1b "Same/Slightly less/Much less"
History of gonadotoxic therapy
Alkylating Agents Cranial radiation > 40 Gy Testicular radiation > 20 Gy Orchiectomy 
